On May 7–8th 2026, the K.G. Jebsen Centre for Myeloid Blood Cancer CMYC, led by Professor Bjørn Tore Gjertsen, organized for the first time an interactive workshop on the topic of statistics in clinical studies. The aim of the workshop was to bring together clinicians, researchers, and statisticians to strengthen collaboration and facilitate exchange of LES MER
VITAL-CML trial has started with the first patient
For the first time in the world, a patient with chronic leukemia is being injected with cancer cells in the hope of becoming cancer‑free as posted on nrk.no and on tv.nrk.no. On the 27th April 2026, Kristian Vik who has had chronic myeloid leukemia for the last 15 years, was injected with irradiated leukemic-derived dendritic LES MER
CMYC and CCBIO Joint Seminar – Richard Dillon
Welcome to the CMYC and CCBIO joint seminar. Speaker: Richard Dillon, Clinical Senior Lecturer in Cancer Genetics in the Department of Medical & Molecular Genetics, School of Basic & Medical Biosciences, at King’s College London and Consultant Haematologist at Guy’s Hospital, London, UK. Title: MRD in AML — what, where, when, and does it matter? LES MER
Mendus announces start of VITAL-CML trial in Chronic Myeloid Leukemia
Mendus has announced the start of the VITAL-CML trial, a Phase 1b study evaluating vididencel in patients with chronic phase CML who have a sub-optimal response to tyrosine kinase inhibitors (TKIs). For CMYC, the trial is of particular interest through the centre’s role in blood sample collection, biobanking and biomarker analyses linked to the study. LES MER
EN